Newsletter from Process and Pharmaceutical Development - RISE PPD
Web version
Newsletter RISE PPD June 2017
We wish all clients and partners a pleasant summer!
Unique solubility improvement methodology for pharmaceutical industry

Solubility is a frequently recurring issue within the pharmaceutical industry and it has been estimated that up to 40% of discovered compounds suffer from this problem.

Read more>
The Marie Skłodowska-Curie Innovative Training Networks
Our joint proposal Transmed in the Marie Skłodowska-Curie Innovative Training Networks has been successful!
Read more>
Molecular Tools for Nucleic Acid Manipulation for Biological Intervention (MMBio)
MMBio is a Marie Curie Initial Training Network set up to provide young researchers with hands-on research experience and formal training in the classically separate disciplines of Chemistry and Biology.
Read more>
Newly employed
Senior scientists employed at RISE PPD
Read more>
OPRD conference in September 2017
OPRD conference at World Trade Center conference center, Stockholm, Sweden 27-29 September 2017
Read more>
Infection Management – Antimicrobial resistance in a holistic perspective
An invitation to a breakfast seminar in Stockholm the 7th of September 2017
Read more>
RISE – The Swedish Research Institute
The RISE institutes Innventia, SP, and Swedish ICT have merged in order to become a stronger research and innovation partner. Through our international collaboration programmes with academia, industry, and the public sector, we ensure the competitiveness of the Swedish business community on an international level and contribute to a sustainable society. Our 2,200 employees support and promote all manner of innovative processes, and our roughly 100 testbeds and demonstration facilities are instrumental in developing the future-proofing of products, technologies, and services. RISE Research Institutes of Sweden is fully owned by the Swedish state.